Reuters logo
BRIEF-Catabasis Pharmaceuticals reports third quarter financial results
November 9, 2017 / 10:16 PM / 10 days ago

BRIEF-Catabasis Pharmaceuticals reports third quarter financial results

Nov 9 (Reuters) - Catabasis Pharmaceuticals Inc

* Catabasis Pharmaceuticals reports third quarter 2017 financial results and reviews business progress

* Q3 loss per share $0.31

* Q3 earnings per share view $-0.33 -- Thomson Reuters I/B/E/S

* Catabasis Pharmaceuticals Inc - co’s current operating plan provides for cash to fund operations through august 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below